会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • BIORESORBABLE COMPOSITION FOR REPAIRING SKELETAL TISSUE
    • 用于修复骨骼组织的生物可降解组合物
    • US20090110732A1
    • 2009-04-30
    • US11995612
    • 2006-07-12
    • Esmaiel Jabbari
    • Esmaiel Jabbari
    • A61K9/10A61K31/74A61K9/14
    • A61K31/765A61L27/18A61L27/365C08L67/04
    • Bioresorbable compositions for treating skeletal tissue are disclosed. The biomedical compositions are formed from a polylactide polymer, a polyglycolide polymer, or a poly(lactic-co-glycolic acid) polymer having a relatively low molecular weight. For instance, the average number molecular weight of the polymer is generally less than 10,000, such as from about 500 to about 5,000. Fumarate groups are incorporated into the low molecular weight polymer that provide crosslinking sites. If desired, ethylene oxide groups and ceramic particles may also be incorporated into the polymer for producing compositions having a variety of properties. For example, the biomedical composition of the present disclosure can be used to treat soft skeletal tissue or to treat hard skeletal tissue. The biomedical compositions are biodegradable and can contain various therapeutic, beneficial and pharmaceutical agents that may be released during degradation of the polymer.
    • 公开了用于治疗骨骼组织的生物可再吸收组合物。 生物医学组合物由聚丙交酯聚合物,聚乙交酯聚合物或具有相对较低分子量的聚(乳酸 - 共 - 乙醇酸)聚合物形成。 例如,聚合物的平均数分子量通常小于10,000,例如约500至约5,000。 富马酸盐基团被并入提供交联位点的低分子量聚合物中。 如果需要,也可以将环氧乙烷基团和陶瓷颗粒引入到用于制备具有多种性质的组合物的聚合物中。 例如,本公开的生物医学组合物可用于治疗软骨骼组织或治疗硬骨骼组织。 生物医学组合物是可生物降解的,并且可以含有可在聚合物降解期间释放的各种治疗,有益和药物。
    • 7. 发明申请
    • Fiber-Reinforced Laminated Hydrogel / Hydroxyapatite Nanocomposites
    • 纤维增强层压水凝胶/羟基磷灰石纳米复合材料
    • US20120226295A1
    • 2012-09-06
    • US12820701
    • 2010-06-22
    • Esmaiel Jabbari
    • Esmaiel Jabbari
    • A61L27/52B29C70/18B82Y40/00
    • B82Y30/00A61L27/44A61L27/52A61L2400/12
    • In accordance with certain embodiments of the present disclosure, a method for forming a laminated nanocomposite is provided. The method includes applying a hydrogel precursor solution to a first layer of poly(L-lactide) nanofiber mesh. A second layer of poly(L-lactide) nanofiber mesh is stacked on the first layer with at least a portion of the hydrogel precursor solution being situated between the first layer and the second layer. The method further includes compressing the first layer and second layer together wherein the first layer and second layer are crosslinked to one another by the hydrogel precursor solution to form a laminated nanocomposite. Furthermore, the laminate layers, prior to crosslinking, can be wrapped around a rod and crosslinked to form a laminated tubular nanocomposite.
    • 根据本公开的某些实施方案,提供了形成层压的纳米复合材料的方法。 该方法包括将水凝胶前体溶液施加到第一层聚(L-丙交酯)纳米纤维网。 在第一层上层叠第二层聚(L-丙交酯)纳米纤维网,其中至少一部分水凝胶前体溶液位于第一层和第二层之间。 该方法还包括将第一层和第二层压在一起,其中第一层和第二层通过水凝胶前体溶液彼此交联以形成层压的纳米复合材料。 此外,层压层在交联之前可以缠绕在棒上并交联以形成层压的管状纳米复合材料。
    • 9. 发明授权
    • Bioresorbable composite for repairing skeletal tissue
    • 用于修复骨骼组织的生物可吸收复合材料
    • US09101654B2
    • 2015-08-11
    • US11995612
    • 2006-07-12
    • Esmaiel Jabbari
    • Esmaiel Jabbari
    • A61K31/765A61L27/36C08L67/04A61L27/18
    • A61K31/765A61L27/18A61L27/365C08L67/04
    • Bioresorbable compositions for treating skeletal tissue are disclosed. The biomedical compositions are formed from a polylactide polymer, a polyglycolide polymer, or a poly(lactic-co-glycolic acid) polymer having a relatively low molecular weight. For instance, the average number molecular weight of the polymer is generally less than 10,000, such as from about 500 to about 5,000. Fumarate groups are incorporated into the low molecular weight polymer that provide crosslinking sites. If desired, ethyl-lene oxide groups and ceramic particles may also be incorporated into the polymer for producing compositions having a variety of properties. For example, the biomedical composition of the present disclosure can be used to treat soft skeletal tissue or to treat hard skeletal tissue. The biomedical compositions are biodegradable and can contain various therapeutic, beneficial and pharmaceutical agents that may be released during degradation of the polymer.
    • 公开了用于治疗骨骼组织的生物可再吸收组合物。 生物医学组合物由聚丙交酯聚合物,聚乙交酯聚合物或具有相对较低分子量的聚(乳酸 - 共 - 乙醇酸)聚合物形成。 例如,聚合物的平均数分子量通常小于10,000,例如约500至约5,000。 富马酸盐基团被并入提供交联位点的低分子量聚合物中。 如果需要,乙烯基氧化物基团和陶瓷颗粒也可以引入到用于制备具有各种性能的组合物的聚合物中。 例如,本公开的生物医学组合物可用于治疗软骨骼组织或治疗硬骨骼组织。 生物医学组合物是可生物降解的,并且可以含有可在聚合物降解期间释放的各种治疗,有益和药物。